Andrea Carolina Barragán-Cárdenas

6PUBLICATIONS
20CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsBiologically active moleculesInstrumental methods (excl. immunological and bioassay methods)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 28, 2025
Fluorescent Peptides Internalize HeLa Cells and Kill Multidrug-Resistant Clinical Bacterial Isolates.

Daniel Castellar-Almonacid, Kelin Johana Cuero-Amu, Jose David Mendoza-Mendoza

|Jul 25, 2025
Non-steroidal anti-inflammatory drugs conjugated to a synthetic peptide exhibit in vitro cytotoxic activity against cervical cancer and melanoma cells.

Daniel Alejandro Castellar-Almonacid, Andrea Carolina Barragán-Cárdenas, Karla Geraldine Rodríguez-Mejia

|Sep 09, 2023
In-house standards derived from doping peptides: Enzymatic and serum stability and degradation profile of GHRP and GHRH-related peptides.

Nicolás Mateo González-López, Luisa María Guerra-Acero-Turizo, Isabella Blanco-Medina

|May 06, 2022
Selective cytotoxic effect against the MDA-MB-468 breast cancer cell line of the antibacterial palindromic peptide derived from bovine lactoferricin.

Andrea Barragán-Cárdenas, Maribel Urrea-Pelayo, Víctor Alfonso Niño-Ramírez

|May 06, 2022
The tetrameric peptide LfcinB (20-25)4 derived from bovine lactoferricin induces apoptosis in the MCF-7 breast cancer cell line.

Jorge Rodríguez Guerra, Andrea Barragán Cárdenas, Alejandra Ochoa-Zarzosa

|Jul 02, 2020
Peptides Derived from (RRWQWRMKKLG)2-K-Ahx Induce Selective Cellular Death in Breast Cancer Cell Lines through Apoptotic Pathway.

Diego Sebastián Insuasty-Cepeda, Andrea Carolina Barragán-Cárdenas, Alejandra Ochoa-Zarzosa

Pageof 1

Frequent Collaborators

6 joint publications

Zuly Rivera-Monroy

6 joint publications

Javier García-Castañeda

2 joint publications

Alejandra Ochoa-Zarzosa

2 joint publications

Joel López Meza